Articles and Publications
-
22 March 2022
In recent days or weeks, there has been an unprecedented wave of articles about the status of intellectual property in Russia, misinterpreting current events.
Read more -
18 March 2022
There are no proposals for a law to waive responsibility for the use of unlicensed software in Russia. Russia continues to be party to all international IP conventions and offers the same level of protection for both Russian and foreign rights holders.
Read more -
16 March 2022
Some Russian and foreign media have made posts stating that the Russian Government has issued a decision abolishing a remuneration for the infringement of the patents owned by patent holders from some countries. This information is not true to the fact.
Read more -
10 March 2022
The situation that has come to exist after sanctions imposed on Russia indeed raises many questions. At the same time it is worth noting that all IP laws remain valid and membership in international conventions is maintained.
Read more -
2 March 2022
The Life Sciences Law Review is an overview of the legal and regulatory frameworks governing pharmaceutical, biotechnology and medical device companies. It covers the major rules and restrictions throughout the life cycle of regulated products, from discovery to clinical trials, the marketing authorisation process and post-approval controls. It also examines the most consequential recent trends and developments in the sector.
Read more
To access this website, we request that you read and accept the Terms of Use.
